Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Agenus Stock Is Jumping Today


Shares of Agenus (NASDAQ: AGEN) were jumping 8.2% as of 11:24 a.m. EDT on Tuesday. The only news related to the company was VBI Vaccines' (NASDAQ: VBIV) announcement that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for cancer vaccine candidate VBI-1901 in treating recurrent glioblastoma, an aggressive type of brain cancer. VBI's experimental vaccine uses GlaxoSmithKline's AS01 adjuvant system, which contains Agenus' QS-21 Stimulon adjuvant.

VBI stock rose a little with the FDA's decision to give Fast Track designation to VBI-1901. The designation could lead to a shorter path to potential approval of the experimental drug. 

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments